Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2016, Article ID 7381943, 7 pages
http://dx.doi.org/10.1155/2016/7381943
Case Report

Diagnostic Challenges of Cryptococcus neoformans in an Immunocompetent Individual Masquerading as Chronic Hydrocephalus

1Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
2Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA

Received 7 April 2016; Accepted 24 May 2016

Academic Editor: Isabella Laura Simone

Copyright © 2016 Kedar R. Mahajan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Voelz and R. C. May, “Cryptococcal interactions with the host immune system,” Eukaryotic Cell, vol. 9, no. 6, pp. 835–846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Datta, K. H. Bartlett, R. Baer et al., “Spread of Cryptococcus gattii into Pacific Northwest Region of the United States,” Emerging Infectious Diseases, vol. 15, no. 8, pp. 1185–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. DeBess, S. R. Lockhart, N. Iqbal, and P. R. Cieslak, “Isolation of Cryptococcus gattii from Oregon soil and tree bark, 2010-2011,” BMC Microbiology, vol. 14, no. 1, article 323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. F. Gazzoni, C. B. Severo, E. F. Salles, and L. C. Severo, “Histopathology, serology and cultures in the diagnosis of cryptococcosis,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 51, no. 5, pp. 255–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Chan, D. Lye, M. K. Win, A. Chow, and T. Barkham, “Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii,” International Journal of Infectious Diseases, vol. 26, pp. 110–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Lui, N. Lee, M. Ip et al., “Cryptococcosis in apparently immunocompetent patients,” Quarterly Journal of Medicine, vol. 99, no. 3, pp. 143–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Zaragoza and A. Casadevall, “Experimental modulation of capsule size in Cryptococcus neoformans,” Biological Procedures Online, vol. 6, no. 1, pp. 10–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Xie, R. Sao, A. Braun, and E. J. Bottone, “Difference in Cryptococcus neoformans cellular and capsule size in sequential pulmonary and meningeal infection: a postmortem study,” Diagnostic Microbiology and Infectious Disease, vol. 73, no. 1, pp. 49–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Almeida, J. M. Wolf, and A. Casadevall, “Virulence-associated enzymes of Cryptococcus neoformans,” Eukaryotic Cell, vol. 14, no. 12, pp. 1173–1185, 2015. View at Publisher · View at Google Scholar
  10. I. Bose, A. J. Reese, J. J. Ory, G. Janbon, and T. L. Doering, “A yeast under cover: the capsule of Cryptococcus neoformans,” Eukaryotic Cell, vol. 2, no. 4, pp. 655–663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. B. C. Haynes, M. L. Skowyra, S. J. Spencer et al., “Toward an integrated model of capsule regulation in Cryptococcus neoformans,” PLoS Pathogens, vol. 7, no. 12, Article ID e1002411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. Dominic, H. Prashanth, S. Shenoy, and S. Baliga, “Diagnostic value of latex agglutination in cryptococcal meningitis,” Journal of Laboratory Physicians, vol. 1, no. 2, pp. 67–68, 2009. View at Publisher · View at Google Scholar
  13. Y.-Y. Lin, S. Shiau, and C.-T. Fang, “Risk factors for invasive Cryptococcus neoformans diseases: a case-control study,” PLoS ONE, vol. 10, no. 3, Article ID e0119090, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. D. R. Boulware, M. A. Rolfes, R. Rajasingham et al., “Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast,” Emerging Infectious Diseases journal, vol. 20, no. 1, pp. 45–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Vidal and D. R. Boulware, “Lateral flow assay for cryptococcal antigen: an important advance to improve the continuum of hiv care and reduce cryptococcal meningitis-related mortality,” Revista do Instituto de Medicina Tropical de São Paulo, vol. 57, supplement 19, pp. 38–45, 2015. View at Publisher · View at Google Scholar
  16. N. Ueno and M. B. Lodoen, “From the blood to the brain: avenues of eukaryotic pathogen dissemination to the central nervous system,” Current Opinion in Microbiology, vol. 26, pp. 53–59, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Stie and D. Fox, “Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin,” Microbiology, vol. 158, part 1, pp. 240–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. N. Day, “Cryptococcal meningitis,” Practical Neurology, vol. 4, no. 5, pp. 274–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. E. Merkler, N. Gaines, H. Baradaran et al., “Direct invasion of the optic nerves, chiasm, and tracts by Cryptococcus neoformans in an immunocompetent host,” The Neurohospitalist, vol. 5, no. 4, pp. 217–222, 2015. View at Publisher · View at Google Scholar
  20. H. C. Eisenman, A. Casadevall, and E. E. McClelland, “New insights on the pathogenesis of invasive Cryptococcus neoformans infection,” Current Infectious Disease Reports, vol. 9, no. 6, pp. 457–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. W. S. Cheon, K.-S. Eom, B. K. Yoo et al., “A case of pulmonary cryptococcosis by capsule-deficient Cryptococcus neoformans,” Korean Journal of Internal Medicine, vol. 21, no. 1, pp. 83–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Levinson, D. C. Silcox, J. W. Rippon, and S. Thomsen, “Septic arthritis due to nonencapsulated Cryptococcus neoformans with coexisting sarcoidosis,” Arthritis & Rheumatism, vol. 17, no. 6, pp. 1037–1047, 1974. View at Publisher · View at Google Scholar · View at Scopus
  23. I. F. Laurenson, J. D. C. Ross, and L. J. R. Milne, “Microscopy and latex antigen negative cryptococcal meningitis,” Journal of Infection, vol. 36, no. 3, pp. 329–331, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kanazawa, M. Ishii, Y. Sato, K. Kitamura, H. Oshiro, and Y. Inayama, “Capsule-deficient meningeal cryptococcosis,” Acta Cytologica, vol. 52, no. 2, pp. 266–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Sugiura, M. Homma, and T. Yamamoto, “Difficulty in diagnosing chronic meningitis caused by capsule-deficient Cryptococcus neoformans,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 10, pp. 1460–1461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. T. Garber and P. L. Penar, “Treatment of indolent, nonencapsulated cryptococcal meningitis associated with hydrocephalus,” Clinics and Practice, vol. 2, no. 1, p. e22, 2012. View at Publisher · View at Google Scholar
  27. M. Del Poeta, “Role of phagocytosis in the virulence of Cryptococcus neoformans,” Eukaryotic Cell, vol. 3, no. 5, pp. 1067–1075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. R. Boulware, M. von Hohenberg, M. A. Rolfes et al., “Human immune response varies by the degree of relative cryptococcal antigen shedding,” Open Forum Infectious Diseases, vol. 3, no. 1, Article ID ofv194, 2016. View at Publisher · View at Google Scholar
  29. X. Li, G. Liu, J. Ma, L. Zhou, Q. Zhang, and L. Gao, “Lack of IL-6 increases blood-brain barrier permeability in fungal meningitis,” Journal of Biosciences, vol. 40, no. 1, pp. 7–12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. P. G. Pappas, “Cryptococcal infections in non-HIV-infected patients,” Transactions of the American Clinical and Climatological Association, vol. 124, pp. 61–79, 2013. View at Google Scholar · View at Scopus
  31. E. Sionov, K. D. Mayer-Barber, Y. C. Chang et al., “Type I IFN induction via poly-ICLC protects mice against cryptococcosis,” PLoS Pathogens, vol. 11, no. 8, Article ID e1005040, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Mora, L. R. Fortunato, L. E. Andrade-Silva et al., “Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis,” PLoS ONE, vol. 10, no. 3, Article ID e0120297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. W. C. Uicker, J. P. McCracken, and K. L. Buchanan, “Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system,” Medical Mycology, vol. 44, no. 1, pp. 1–11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-H. Liao, C.-Y. Chi, Y.-J. Wang et al., “Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis,” Journal of Microbiology, Immunology and Infection, vol. 45, no. 4, pp. 296–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. D. Nosanchuk, S. Shoham, B. C. Fries, D. S. Shapiro, S. M. Levitz, and A. Casadevall, “Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient,” Annals of Internal Medicine, vol. 132, no. 3, pp. 205–208, 2000. View at Google Scholar · View at Scopus
  36. S. Dumontet, A. Scopa, S. Kerje, and K. Krovacek, “The importance of pathogenic organisms in sewage and sewage sludge,” Journal of the Air and Waste Management Association, vol. 51, no. 6, pp. 848–860, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. R. A. Hajjeh, L. A. Conn, D. S. Stephens et al., “Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group,” Journal of Infectious Diseases, vol. 179, no. 2, pp. 449–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Viereck, N. Chalouhi, D. I. Krieger, and K. D. Judy, “Cryptococcal ventriculoperitoneal shunt infection,” Journal of Clinical Neuroscience, vol. 21, no. 11, pp. 2020–2021, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. L.-M. Tang, “Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus,” Surgical Neurology, vol. 33, no. 5, pp. 314–319, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. M. K. Park, D. R. Hospenthal, and J. E. Bennett, “Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting,” Clinical Infectious Diseases, vol. 28, no. 3, pp. 629–633, 1999. View at Publisher · View at Google Scholar · View at Scopus